Hong Die, Liu Jia, Hu Ying, Lu Xiaonan, Li Baohua, Li Yang, Hu Dongxiao, Lu Weiguo, Xie Xing, Cheng Xiaodong
Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Women's Reproductive Health Laboratory of Zhejiang Province, Zhejiang University, Xueshi Rd 1#, Hangzhou, 310006, China.
BMC Cancer. 2017 Feb 15;17(1):136. doi: 10.1186/s12885-017-3124-9.
The integration of HR-HPV genome into host DNA is regarded as a key step for the development of cervical cancer. However, HR-HPV genome indeed exists as episome except for integrant. It may be alternative mechanisms in episome-associated carcinogenesis, although, by which HPV 16 episome induces cervical carcinogenesis is unclear now.
Ninety-three invasive cervical cancer tissues with HPV16 positive were collected. Viral physical status was calculated from comparing E2 to E6-copies and detection of viral load was made with realtime-PCR using copy numbers of E6. HPV16 E6 mRNA transcript levels were measured by realtime-PCR. The methylation frequency of HPV16 promoter was detected by PCR and pyrosequencing.
In 93 samples, 21.5% (20/93) presented purely integrated viral genome, 53.8% (50/93) mixed viral genome, and 24.7% (23/93) purely episomal viral genome. Mean E6 expression in samples with purely episomal viral genomes was 7.13-fold higher than that with purely integrated viral genomes. Meanwhile, viral load in samples with purely episomal viral genomes was 4.53-fold higher than that with purely integrated viral genomes. E6 mRNA expression increased with the viral load in purely episomal cases. There were no differences of mean methylation frequency between purely episomal and integrated virus and among five CpG positions of HPV16 promoter for all samples. And there also was no correlation between E6 mRNA expression and methylation of HPV16 promoter among all samples with purely HPV16 episomal virus.
HPV16 with the purely episomal viral genomes exists in a definite proportion of invasive cervical cancer, and episomal HPV16 also overexpresses E6 mRNA, probably through a high level of viral load.
高危型人乳头瘤病毒(HR-HPV)基因组整合入宿主DNA被视为宫颈癌发生发展的关键步骤。然而,除整合型外,HR-HPV基因组确实以游离体形式存在。尽管目前尚不清楚HPV 16游离体诱导宫颈癌发生的替代机制,但在游离体相关的致癌过程中可能存在其他机制。
收集93例HPV16阳性的浸润性宫颈癌组织。通过比较E2与E6拷贝数计算病毒物理状态,使用E6拷贝数通过实时定量PCR检测病毒载量。通过实时定量PCR测量HPV16 E6 mRNA转录水平。通过PCR和焦磷酸测序检测HPV16启动子的甲基化频率。
在93个样本中,21.5%(20/93)呈现纯整合病毒基因组,53.8%(50/93)为混合病毒基因组,24.7%(23/93)为纯游离病毒基因组。纯游离病毒基因组样本中的平均E6表达比纯整合病毒基因组样本高7.13倍。同时,纯游离病毒基因组样本中的病毒载量比纯整合病毒基因组样本高4.53倍。在纯游离体情况下,E6 mRNA表达随病毒载量增加。所有样本的纯游离体和整合病毒之间以及HPV16启动子的五个CpG位置之间的平均甲基化频率没有差异。在所有纯HPV16游离病毒样本中,E6 mRNA表达与HPV16启动子甲基化之间也没有相关性。
纯游离病毒基因组的HPV16存在于一定比例的浸润性宫颈癌中,游离体HPV16也可能通过高水平的病毒载量使E6 mRNA过表达。